Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Reagent Qualification for Method Development – V 2.0

Posted on By

Analytical Method Development: Reagent Qualification for Method Development – V 2.0

SOP for Qualification of Reagents Used in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/036/2025
Supersedes SOP/AMD/036/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the procedure for qualifying reagents used in the Analytical Method Development (AMD) department. The aim is to ensure that all reagents used for method development and validation are appropriate for their intended use, traceable, and conform to applicable regulatory and GMP standards.

2. Scope

This SOP applies to all chemical reagents, buffers, indicators, titrants, and solvents used in the AMD laboratory for developing, optimizing, or validating analytical procedures for APIs, excipients, and formulations.

3. Responsibilities

  • Analytical Scientist: Selects and initiates qualification for new or critical reagents used in method development.
  • QA: Reviews and approves reagent qualification records and ensures traceability.
  • Store Personnel: Ensures proper storage and labeling of reagents with status tags.
  • Head – AMD: Approves qualified reagent status and resolves any discrepancies.
See also  Analytical Method Development: Risk Assessment in Analytical Method Development - V 2.0

4. Accountability

The Head of AMD is accountable for ensuring that only qualified reagents are used in the development and validation of analytical methods.

5. Procedure

5.1 Reagent Selection

  1. All reagents shall be of analytical reagent (AR), HPLC, or GC grade, unless otherwise justified.
  2. Reference supplier specifications, compendial monographs, and material safety data sheets (MSDS).
  3. Assign a unique Reagent ID number and document in Annexure-1: Reagent Qualification Log.

5.2 Receiving and Preliminary Inspection

  1. Inspect reagents upon receipt for:
    • Supplier name and batch number
    • COA availability and compliance
    • Expiry date, manufacturing date, and packaging integrity
  2. Initial assessment to be recorded in Annexure-2: Reagent Receipt and Inspection Checklist.

5.3 Reagent Testing and Verification

  1. If COA is available:
    • Verify identification and assay using one or more analytical techniques (UV, IR, titration)
    • Compare values against pharmacopeial or internal specifications
  2. If COA is not available or if reagent is critical (e.g., titrant, pH modifier):
    • Conduct full qualification testing as per Annexure-3: Reagent Testing Record
  3. Qualified reagents shall be assigned a status tag: “Qualified for Use in AMD”

5.4 Labeling and Documentation

  1. Each reagent container shall have a legible label stating:
    • Reagent name
    • Reagent ID
    • Date of opening
    • Use before date
    • Qualified By & Date
  2. Update the Reagent Master List and qualification tracker maintained by QA.
See also  Analytical Method Development: Preparation of Method Development Protocol - V 2.0

5.5 Retesting and Requalification

  1. Retest intervals:
    • 6 months for aqueous buffers
    • 12 months for acids, bases, or non-volatile solvents
  2. Requalification to be documented in Annexure-4: Reagent Requalification Form.

5.6 Storage and Handling

  1. Store qualified reagents in clean, ventilated chemical cabinets at designated temperature and humidity conditions.
  2. Highly sensitive reagents (e.g., perchloric acid, iodine) to be stored with additional secondary containment.
  3. Maintain usage logs for critical reagents in Annexure-5: Critical Reagent Usage Log.

5.7 Non-Conformance Management

  1. If reagent fails qualification:
    • Label as “Rejected”
    • Segregate and record deviation in accordance with SOP/QMS/042/2025
  2. Perform impact analysis for any methods developed using unqualified reagents.

6. Abbreviations

  • AMD: Analytical Method Development
  • QA: Quality Assurance
  • COA: Certificate of Analysis
  • MSDS: Material Safety Data Sheet
  • SOP: Standard Operating Procedure

7. Documents

  1. Reagent Qualification Log – Annexure-1
  2. Reagent Receipt and Inspection Checklist – Annexure-2
  3. Reagent Testing Record – Annexure-3
  4. Reagent Requalification Form – Annexure-4
  5. Critical Reagent Usage Log – Annexure-5

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • USP General Chapter <841> – Specific Gravity
  • WHO TRS 986 Annex 2 – Good Practices for Quality Control Laboratories
  • 21 CFR Part 211.84 – Testing and Approval of Components

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Reagent Qualification Log

Reagent ID Reagent Name Supplier Batch No. Qualification Date
RG-2025-017 Sodium Hydroxide Rankem NA25K7 02/05/2025

Annexure-2: Reagent Receipt and Inspection Checklist

Parameter Status Remarks
COA Present Yes Verified
Packaging Intact Yes No leakage
Expiry Date Valid Dec 2026

Annexure-3: Reagent Testing Record

Test Performed Method Result Status
Identification (IR) USP Matches spectrum Pass

Annexure-4: Reagent Requalification Form

Reagent ID Requalification Date Test Performed Status
RG-2025-012 05/11/2025 pH Adjustment Efficiency Pass

Annexure-5: Critical Reagent Usage Log

Date Reagent ID Analyst Purpose Remarks
06/05/2025 RG-2025-017 Ajay Verma Titration Buffer Prep Used as per SOP

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added new annexures for requalification and usage tracking GMP audit compliance
See also  Analytical Method Development: System Suitability Testing Parameters Design - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: BA-BE Studies: SOP for Clinical Trial Photography and Video Recording – V 2.0
Next Post: Biosimilars: SOP for Monitoring CO₂ Levels in Incubators – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version